东北制药 (000597)

NORTHEAST PHARMACEUTICAL GROUP CO.,LTD

ASZ

Tags

Special Purpose LoansImmunotherapyInnovative DrugsPharmaceutical ManufacturingVitaminsFree Cash FlowAssisted Reproduction

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 142708.83
  • Circulating A-Shares(W): 140931.60
  • Earnings Per Share(RMB): 0.1209
  • Net Assets Per Share(RMB): 3.7585
  • Operating Revenue(W RMB): 547808.51
  • Total Profit(W RMB): 23982.98
  • Net Profit Attributable to Parent(W RMB): 17270.31
  • Net Profit Growth Rate(%): -16.96
  • Weighted Return on Equity(%): 3.22
  • Operating Cash Flow Per Share(RMB): 0.2660
  • Undistributed Profit Per Share(RMB): 0.9098
  • Capital Reserve Per Share(RMB): 1.7424

2. Main Business

The main business covers:

  • Chemical Pharmaceuticals (including APIs and preparations)
  • Pharmaceutical Commerce (wholesale and chain)
  • Pharmaceutical Engineering (design, manufacturing, and installation)
  • Biopharmaceuticals (biological diagnostic reagents)

3. Company Basic Information

  • Company Name: Northeast Pharmaceutical Group Co., Ltd.
  • Listing Date: 1996-05-23
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 8 Kunminghu Street, Shenyang Economic and Technological Development Zone, Liaoning Province
  • Website: www.nepharm.com.cn
  • Company Profile：The company was established by Northeast Pharmaceutical Group Company in 1992. Initially, the net assets of three affiliated enterprises were converted into 117 million state shares, 8 million private placement corporate shares, and 24.75 million employee shares. After the initial public offering in May 1996, the total shares at listing were 194.75 million. The 5 million internal employee shares were traded together with the public shares using the quota.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Jiangxi Fangda Iron and Steel Group Co., Ltd. General Legal Person 45786.13 32.49
2 Liaoning Fangda Group Industrial Co., Ltd. General Legal Person 32906.87 23.35
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 1253.21 0.89
4 Southern China Securities CSI 1000 ETF Fund 654.05 0.46
5 Western Lead CSI 1000 Index Enhanced Securities Investment Fund Class A Fund 54.03 0.04
6
7
8
9
10

5. Concept Sectors

  • Immunotherapy
  • Vitamins
  • Assisted Reproduction
  • Innovative Drugs
  • Special Loans
  • Free Cash Flow

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information